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Abstract: This work reports on the synthesis, with the thermally induced phase separation (TIPS)
technique, of poly (L-lactide) (PLLA) scaffolds containing Fe-doped hydroxyapatite (FeHA) particles
for bone regeneration. Magnetization curves and X-ray diffraction indicate two magnetic particle
phases: FeHA and magnetite Fe3O4. Magnetic nanoparticles (MNPs) are approximately 30 ± 5 nm in
width and 125± 25 nm in length, and show typical ferromagnetic properties, including coercivity and
rapid saturation magnetization. Scanning electron microscopy (SEM) images of the magnetic scaffolds
reveal their complex morphology changes with MNP concentration. Similarly, at compositions of
approximately 20% MNPs, the phase separation changes, passing from solid–liquid to liquid–liquid
as revealed by the hill-like structures, with low peaks that give the walls in the SEM images a surface
pattern of micro-ruggedness typical of nucleation mechanisms and growth. In vitro degradation
experiments, carried out for more than 28 weeks, demonstrated that the MNPs delay the scaffold
degradation process. Cytotoxicity is appreciated for FeHA content above 20%.
Keywords: Fe-doped hydroxyapatite; poly (L-lactide); scaffolds; magnetism; cytotoxicity
1. Introduction
A few years ago, rapid progress in tissue engineering led to the development of certain
tissues to replace those damaged either by trauma or disease, or due to congenital defects in
sequential order: [1]. Bone regeneration materials are designed to stimulate osteoinductivity,
osteoconductivity, osteointegration, biocompatibility, resorbence, and bone-like mechanical properties.
Magnetic materials can be introduced into the scaffolds, in order to promote bone formation and cell
growth with some of these properties [2]. Magnetic nanoparticles (MNPs) that can be manipulated
by an external magnetic field have been used over the past twenty years in both in vivo and in vitro
biomedical applications [3]. MNPs should be biocompatible and biodegradable for therapeutic
applications. The iron ions in MNPs containing iron and iron oxides, after having metabolized, are
added to the iron deposits in the body and are finally incorporated by the erythrocytes or red blood
corpuscles into the haemoglobin [4,5]. Some of the therapeutic applications include hyperthermia [6]
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in which the MNPs transmit heat to concentrate higher temperatures in a specific zone without
affecting healthy tissue. Another application is the liberation of pharmaceutical compounds where
they can be directed, for example to a tumor, in a selective way, by the application of an external
magnetic field [7]. They may likewise be used in non-invasive diagnostic applications such as magnetic
resonance imaging (MRI) where the MNPs act as contrast material due to the local modification they
produce in the magnetic fields, electric field gradients, and radio waves depending of the type of
imaging that is employed.
Some in vitro studies have indicated that magnetic particles have effects on bone marrow-derived
mesenchymal stem cells (MSCs), as differentiation, proliferation, intracellular calcium levels,
and matrix formation [8,9]. However, one of the problems with MNPs is the strength of the external
magnetic field that must be applied to ensure an appropriate time of residence. This problem of timing
can be solved by introducing magnetic scaffolds close to the point of medical treatment, with minimally
invasive surgery. The scaffolds respond directly to the external magnetic field, thereby circumventing
the difficulties of magnetic design guides [9]. With respect to this scope, magnetically active
microenvironments have been developed showing increased MC3T3-E1 pre-osteoblast cell proliferation
both under magnetic and magnetoelectric stimuli [10]. The latter approach is particularly interesting
for bone tissue engineering due to the natural piezoelectric properties of bone [11] and can be achieved
when the magnetic fillers are introduced in electroactive polymer-based scaffolds such as the ones
based on poly (vinylidene fluoride) (PVDF) or poly (L-lactide) acid (PLLA), [11] among others.
These types of scaffolds should show appropriate long-lasting mechanical properties, hence the
use of nanohydroxyapatite (nHA), which has similar properties to the mineral components of
calcium hydroxyapatite in bones. Some authors have synthesized iron-doped hydroxyapatite
Fe2+ and Fe3+ [8,9,12–14] for medical applications such as magnetic drug carrier, reference [7]
and hyperthermia [12], among others. Similarly, magnetic nanospheres have been synthesized
from Fe-doped hydroxyapatite [4,13]. A few have synthesized scaffolds with ferrofluids or with
magnetite [14].
In this paper, the authors report on the development of highly porous magnetic PLLA scaffolds
with different concentrations of nanohydroxyapatite doped with iron. The nHA particles are bioactive
and biocompatible, and the fact of doping with iron provided them with magnetic properties.
The results of an indirect cytotoxicity evaluation of the scaffolds are described using an adaptation of
the ISO 10993-5 standard test method. A full characterization of the synthetized nanoparticles and a
study of their magnetic behavior and the in vitro degradation of the scaffolds was performed. In vitro
results cannot be extrapolated to in vivo but some conclusions offer very valuable information on the
in vivo behavior of these devices for tissue engineering.
2. Experimental Section
2.1. Materials
Poly-L-lactide (PLLA) with a content of residual solvent and residual monomer, in each case
of less than 0.01%, was purchased from Biomer L9000 (Biomer, Forst-Kasten, Krailling, Germany).
A 1,4 dioxane (Panreac Barcelona, Spain) was used as the solvent. The weight-average relative
molecular weight Mw = 141,940, Mn = 95,680 and the polydispersity Mw/Mn = 1.4835 of PLLA
were measured with gel permeation chromatography (GPC) (Perkin Elmer 200, Waltham, MA, USA)
in tetrahydrofuran (THF). GPC was prepared with a THF solvent using a Perkin Elmer
200 reflective index detector. Calibration adhered to polystyrene standards at a flow rate of
1ml/min. Phosphate-buffered saline (PBS) solution in water purchased from Fluka Analytical
(Sigma-Aldrich, Saint Louis, MO, USA), was used as the degradation fluid at a pH of 7.2.
The Fe-doped hydroxyapatite (FeHA) nanoparticles were synthesized with FeCl2·4H2O (98% purity,
Sigma-Aldrich, Darmstadt, Germany), FeCl3·6H2O (97% purity, Sigma-Aldrich, Germany), Ca(OH)2
(Honeywell-Fluka, Morristown, NJ, USA), and distilled water (p.a. Panreac, Barcelona, Spain).
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2.2. Synthesis of Magnetic Nanoparticles
The nanohydroxyapatite precipitate doped with iron was obtained by following the method
proposed by Tampieri et al. [12], adding a solution drop by drop of phosphoric acid to a basic
suspension of Ca(OH)2, containing Fe2+ and Fe3+ ions, with constant agitation and heating over
two hours. The total concentrations of Fe ions as opposed to the Ca ions were adjusted to obtain
Fe/Ca = 20 mol %. The reaction products were maintained under stirring and heating for one hour
at 60 ◦C. Subsequently, the precipitate was left for 24 h to age at room temperature with no stirring.
The precipitate was separated from the mother solution by means of centrifugation at 5000 rpm and
rinsed with distilled water three times. It was then lyophilized, crushed in an agate mortar and, finally,
passed through a sieve with a mesh size of 150 µm.
2.3. Fabrication of PLLA/FeHA Porous Scaffolds
The protocol for the synthesis of the PLLA/FeHA composite scaffolds previously described in [15]
was followed. In short, a PLLA solution was prepared in 1,4 dioxane (2.5% (w/v)). Then, a homogenous
dispersal of FeHA particles in the above suspension was ensured with ultrasonic stirring. Freezing
and freeze-drying weight (LyoQuest of Telstar, Barcelona, Spain) of the resultant solutions for five days
yielded highly porous composite scaffolds with different FeHA proportions of total polymer mass
(0%, 10%, 30%, 70%, and 80%). This method yielded porous foam scaffolds with porosities of up to 90%.
2.4. Cytotoxicity Assay
Membrane sterilization: 0.1 g·mL−1 membranes were cut and sterilized under UV for 2 h before
cell seeding (1 h each side) for the in vitro assays. Then, each sample was washed five times for five
minutes in a phosphate-buffered saline (PBS, Sigma-Aldrich, Saint Louis, MO, USA) solution.
Cytotoxicity assay: an adaptation of the ISO 10993-5 standard test method was used to conduct
the indirect cytotoxicity evaluation of the samples. Briefly, the samples were immersed in a 24-well
tissue culture polystyrene plate, to prepare the extraction media, with Dulbbecco’s Modified Eagle’s
Medium-high glucose (DMEM) containing 1 g·L−1 glucose (Sigma-Aldrich, Saint Louis, MO, USA)
supplemented with 10% of fetal bovine serum(FBS) (Biochrom, Canbourne, CB, UK) and 1%
penicillin/streptomycin P/S (Biochrom, Canbourne, CB, UK). They were immersed at 37 ◦C in a
95% humidified air containing 5% CO2 and incubated for 24 h.
Similarly, the MC3T3-E1 cells were seeded in a 96-well tissue culture polystyrene plate at
a density of 3 × 104 cells·mL−1 and then incubated for 24 h to allow the cell attachment on
the plate. Then, the culture medium was removed from the 96-well tissue culture polystyrene
plate and the wells (100 µL) were filled with the as-prepared extraction media (from the samples).
Subsequently, the cells were incubated for 72 h and then, the evaluation of the cell viability was
quantified with a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, Sigma-Aldrich,
Saint Louis, MO, USA) assay. The cell culture medium was employed as a negative control and 20%
dimethylsulfoxide (DMSO, Sigma-Aldrich, Saint Louis, MO, USA) was used as a positive control.
The mitochondrial activity of the cells, which reflects the viable cell number, was measured with
the MTT assay. The medium of each well was removed after 72 h, replacing it with the fresh medium
containing 10% MTT solution (stock solution of 5 mg MTT·mL−1 in PBS). The viable cells with active
metabolism converted the MTT into a purple-colored formazan product. Following an incubation period
of 2 h, the MTT crystals were dissolved with DMSO and the optical density was measured at 570 nm.
Four replicate samples and controls yielded all the quantitative results and were analyzed as the
average of viability ± standard deviation (SD).
Equation (1) was used to calculate the percentage of cell viability.
Cell viability (%) =
absorbance of sample
absorbance of negative control
(1)
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2.5. In Vitro Degradation
For the degradation experiment, the scaffolds were cut into rectangular pieces and weighed.
They were then immersed in glass test tubes containing 10 mL of PBS. The tubes were put into an
incubator at 37 ◦C. The pieces were recovered and wiped after 1, 5, 8, 10, 12, 16, 20, 25, and 28 weeks
and then weighed to determine their water absorption. A pH meter PCE 228 (PCE Instruments, Pons,
Alicante, España) was used to determine the pH alteration in the medium. The degraded scaffolds were
dried over two weeks to a constant weight in a freeze-dryer (LyoQuest of Telstar, Barcelona, Spain).
The following equation was used to calculate the water absorption percentage, Wa%: *
Wa% =
Ww−Wr
Wr
× 100 (2)
where, Ww was the weight of the wet/swallow sample after removing the surface water. Wr was the
residual weight of a dry scaffold after degradation.
Weight loss percentage (WL%) was estimated with the following equation:
WL% =
Wo−Wr
Wo
×100 (3)
where Wo was the original mass of the scaffold.
2.6. Scanning Electron Microscopy (SEM) and Transmission Electron Microscopy (TEM) Analysis
SEM (HITACHI S-3400N, Tokyo, Japan) was used to study the scaffold morphology.
A gold coating was applied to the samples, prior to analysis, in a JEL Ion Sputter JFC-1100
((JEOL, Peabody, MA, USA) at 1200 V and 5 mA, to avoid sample charging under the electron beam.
A PHILIPS CM120 Biofiller with a STEM module and elemental mapping and filtering of
images with electron energy-loss spectroscopy (EELS) was used to perform the Transmission Electron
Microscopy (Philips Ibérica, Madrid, España).
2.7. X-ray Diffraction Analysis
An Xpert diffractometer PANalytical PRO (Philips, Almelo, Netherlands) equipped with a copper
tube (λCuKαmedia = 1.5418 Å, λCuKα 1 = 1.54060 Å, and λCuKα 2 = 1.54439 Å), a vertical goniometer
(Bragg-Brentano geometry) a programmable divergence slit, an automatic sampler, a secondary
graphite monochromator, and a PIXcel detector (Philips, Almelo, Netherlands)) was used to perform
X-ray diffraction (XRD) analysis.
2.8. Magnetic Analysis
Magnetic measurements were performed at physiological temperature (310 K) on a Vibrating
Sample Magnetometer (VSM). The magnetometer, developed at the University of the Basque Country,
was calibrated with pure (99.995%) nickel. The available magnetic field range was ±1.8 Tesla (18 kG),
and it had a resolution of ±20 µTesla (0.2 G), and a moment sensitivity of 10−8 Am2 (10−5 emu).
The data were normalized to the sample mass, determined by an analytical balance calibrated to
±0.05 mg. In all cases, the overall accuracy of the magnetic saturation values was over 1%.
2.9. Differential Scanning Calorimetry (DSC)
A TA Instruments calorimeter at a range of 4–120 ◦C was used to perform the DSC measurements.
After heating the samples at 5 ◦C/min (first run), cooling them at 10 ◦C/min (second run), and finally
heating them at 5 ◦C/min (third run), the degree of crystallinity, Xc%, of the samples was evaluated
with the following equation:
Xc% = 100 (∆Hm1/∆H◦m) (4)
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where ∆Hm1 is the enthalpy of melting measured in the first run and ∆H◦m is the enthalpy of melting
of a totally crystalline PLLA (∆H◦m = 93 J/g) [16]. The crystallizable fraction (CF%) of the samples
was calculated with the following equation [8]:
CF% = 100 (∆Hc/∆Hm1) (5)
2.10. Fourier-Transform Infrared (FTIR)Spectroscopy
Infrared spectra of the samples were recorded on a Thermonicolet Avatar 370 Fourier-transform
infrared (FTIR, Thermo Electron Corporation, Waltham, MA, USA) spectrophotometer equipped with
an attenuated total reflectance attachment with ZnSe crystal. Spectra were repeatedly scanned 32 times
between 4000 and 650 cm−1 at a resolution of 4 cm−1.
3. Results and Discussion
3.1. Characterization of FeHA
The results of X-ray powder diffraction (XRD) are detailed in Figure 1, in which both the sites
and the intensities of the diffraction peaks are shown. The circled peaks representing Ca5(PO4)3(OH)
are consistent with the standard pattern for JCPDS Card No. 25–166.
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Figure 1. Cu Kα diffractogram of the synthetized nano-Hydroxyapatite (nHA), (*) Magnetite r flections,
(◦) nHA reflectio s.
The characteristic peaks for JCPDS Card No. 19–629 indicated a very high content of magnetite
(marked with an asterisk in Figure 1 in the synthesized FeHA, which might have been due to the
high temperature of the synthesis (60 ◦C). The results were quite different from the ones presented by
Panseri et al. because of the very high content of magnetite [2].
Structural analysis provided evidence of the sub titution of ions Fe (F 2+ and Fe3+) in the HA
structure. The cry tallite size (D) a around 30 nm was determined using Scherrer’s formula [17].
FULLPROF [18] software w s used to calculate the full width and half of the m ximum int nsity.
The SEM and TEM analysis of the FeHA nanoparticles’ morphology showed a large number of
dark spots corresponding to inclusions of iron-rich phases and quite heterogeneously sized particles of
approximately 25 nm in width and 100–150 nm in length (see Figures 2 and 3, respectively).
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Figure 3. Transmission electron microscopy (TEM) micrographs of FeHA nanoparticles.
3.2. Magnetic Properties
F gure 4 shows the hyster sis loops of the PLLA/FeHA scaffolds at 37 ◦C, as m asured in a
Vibrating Sampl Magnetomete (VSM). The main magn tic paramet rs, saturation m gnetization
(Ms) and coercive field (Hc), are listed in Table 1. The tru content of FeHA is included, calculated
from the experimental value of the magnetization. The coercivity of the initi l FeHA and of all the
composite scaffolds was quite similar: µoHc ≈ 2–3 mT. The lowest coercivity level was observed
in the PLLA/FeHA 80 wt % scaffold. This value, although it was low for the largest nanoparticle
concentrations, was not indicative of superparamagnetic (SPM) behavior [12]. The ferromagnetic (FM)
character of the nanoparticles was also clear from the rapid saturation of the magnetization.
Table 1. Nominal FeHA content (wt %), Ms = Magnetization at 1.5 T, in the saturated region (Am2/kg
of FeHA), µ0Hc = coercivity (mT), and FeHA content recalculated from the measured magnetization.
% FeHA Nominal Moment (Am2/kg FeHA) µ0 Hc (mT) % FeHA Recalculated
100 (1) 4.45 3.18 -
10 5.58 2.77 12.5
20 6.16 2.73 27.6
30 5.33 2.64 36
50 4.86 2.65 54.5
70 4.77 2.50 74.9
80 4.86 2.27 87.2
(1) Pure FeHA powder taken as reference.
Nanomaterials 2018, 8, 678 7 of 16
The “wasp-waist”-shaped loops, shown in the inset of Figure 2, indicate a combination of low
Hc and high Hc compounds, in the two magnetic nanoparticle phases. The low Hc phase was linked
to FeHA and the high Hc phase was linked to a segregation of some magnetite (Fe3O4) during the
preparation of the FeHA particles.
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3.3. SEM
In this section, the morphology of the magnetic scaffolds manufactured with the thermally
induced phase separation (TIPS) technique, the influence of magnetic nanoparticle concentrations,
and the in vitro degradation process are all studied. It may be seen, in Figure 5, that the scaffolds
with a lower number of nanoparticles present an anisotropic tubular morphology with a ladder-like
internal structure and pore sizes of 25–250 µm, characteristic of a solid–liquid phase separation
(see Figure 5a,c,d) [19]. The larger amounts of FeHA scaffold pores were of a smaller size
(approximately 15–180 µm), and presented a much more isotropic morphology, due to the perturbation
produced by the nanoparticles in the crystallization of the solvent (see Figure 5e,g). In fact, the walls
of the pores contain hill-type structures, with small peaks (green circles) that gave the walls a
micro-roughness pattern, typical of nucleation and growth that correspond to liquid–liquid phase
separation [20–22].
As the process of degradation advanced, changes in scaffold morphology may be appreciated,
showing a change from a smooth to a rougher appearance, with micro-porosities appearing on the
scaffold walls (red circles) and particle coalescence on the walls of the porous carrier (see Figure 5b)
(blue circles). This might be due to the degradation that gradually deposits a layer of FeHA from the
surface of the scaffold into the internal pores.
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3.4. Thermal Analysis
The DSC data are shown in Table 2. The values of Tm = 184 ◦C, Tc = 56 ◦C, and Tg = 96 ◦C
remained constant during in vitro degradation, in PBS, at pH 7.2, over 25 weeks. Some authors have
reported decreasing of Tc and Tg after 12 months for scaffolds without nanoparticles [20]. ∆Hc, ∆Hm,
and Xc% decreased with degradation time, although some samples (10 wt % FeHA and 30 wt % FeHA)
slightly increased crystallinity around the 12th week of degradation. This increase, discussed in the
literature [15,23–27], is attributed to the splitting of the chains, which as they shorten, reorder more
easily and form crystals.
Table 2. Parameters obtained by thermal analysis on the PLLA-FeHA system: dt (weeks) = degradation
time in weeks, Tm = melting point (◦C), ∆Hm = melting enthalpy (kJ/kg), Tg = glass transition
temperature (◦C), Tc = crystallization temperature (◦C), ∆Hc = crystallization enthalpy (kJ/kg),
Xc = crystalline fraction (%), calculated as Xc% = 100 [(∆Hm1 − ∆Hcc)/∆Hm0] with ∆Hm0 = 93 J/g
[16], CC = crystallization capacity (%), calculated as: CF % = 100(∆Hc/∆Hm1).
PLLA/FeHA%
dt (Week)
First Run Second Run
Xc% CF%
Tm (◦C) ∆Hm (J/g) Tcc (◦C) ∆Hcc (J/g) Tg (◦C) Tc (◦C) ∆Hc (J/g)
0% 184 41.1 76 4.7 56 96 2.3 39 6
10% 183 44.1 75.5 3.4 58.5 98 9.7 44 22
4 dt 183 41.8 76.5 2.3 58 97 8.8 42 21
8 dt 182 43.2 75 1.9 59 97 6.9 44 16
12 dt 182 44 - - 58 98 6.8 47 15
16 dt 182 40.7 - - 57 99 6.4 44 16
20 dt 182 40.1 77.5 1.5 58 97 5.7 42 14
25 dt 181 38 77 2.7 56 98 5.2 38 14
20% 184 36.1 76.1 4.9 60 101 18.2 33.5 50
30% 183 31.7 - - 61 103 20.4 34 64
4 dt 183 24.2 77 2.5 62 105 19 23 78
8 dt 182 28.8 77 1.43 61 102 17 29 59
12 dt 182 29 86 1.3 61 103 15 30 52
16 dt 181 30.3 - - 58 100 12 33 40
20 dt 181 28.6 74 2.3 57 98.5 10 28 35
The crystallinity of the polymer composites, as shown in Table 2, decreased during the degradation
process, unlike what the pure polymer does. The crystalline fraction (CF) simultaneously increased
in almost inverse proportionality with the crystallinity, that is, the lower the polymer crystallinity,
the higher the CF of the samples. This is a behavior that might be related to the polymeric chain length.
The samples with the lowest crystallinity had shorter polymeric chains where they were affected
by degradation and therefore showed a loss of order (i.e., lower crystallinity); in the second run,
these shortened polymeric chains, due to their reduced molecular weight, were able to crystallize, with
a consequent increase in CF. It may, therefore, be affirmed that the samples with the lowest polymer
crystallinity and the highest CF correspond to the lowest polymeric chain length [28].
3.5. Water Uptake
Figure 6a shows the water absorption percentages as a function of degradation time. We can see
from these curves that the introduction of bioactive magnetic nanoparticles in the scaffolds increased
their capacity to absorb PBS; some samples reached absorption percentages of approximately 250%
at 25 weeks of in vitro degradation. In a previous paper on PLLA/nHA [29], the highest absorption
(approximately 200%) occurred in the polymer without nHA and the addition of nanoparticles
decreased the absorption levels. The doping of nHA with Fe2+ and Fe3+ in the form of magnetite
increased water absorption. Such a behavior was expected in a composite polymer material that is
hydrophobic, whereas FeHA is very hydrophilic. Water is a degradation medium and its absorption
levels are determined by the balance between the oligomer dissolution rate and the water uptake of
residual material in the solution. The rate of polymer hydrolysis was dependent on the amount of
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water hydrogen bound to the oxygen in the ester carbonyl groups [29–31]. The absorption of large
amounts of water will not mean an increase in the degradation rate.Nanomaterials 2018, 8, x FOR PEER REVIEW  10 of 16 
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3.6. pH
The release of acidic products, due to hy rol sis, gives a idea of the pr gress of the degradation
process [32]. In Figure 6b, we can see the pH chang s of the PLLA/FeHA scaffolds as a function of
degradation time. The pH values decreased very slowly up until the 25th week of the degradation process.
The highest variations in pH were experienced by the composition of the highest nanoparticle contents
(PLLA/FeHA 70 wt %), result that were coincident with the higher water absorption and weight loss.
3.7. Mass and Weight Loss
The first consequence of the degradation was the decrease of molecular weight, followed by
the reduction of the tensile strength and, finally, the decrease of mass. Table 3 presents the changes
in the weight-average relative molecular weight, Mw, Mn, and polydispersity I = Mw/Mn against
degradation time. The Mw of the PLLA used to manufacture the scaffolds must be higher than
50,000 g/moL, for its application in bone fixation devices to be feasible [33].
Table 3. Molecular weight: weight average (Mw), number average (Mn), and polydispersity index (I)
of the PLLA/FeHA system.
Sample Degradation Time (Weeks) Mw Mn I
PLLA 0 144,221 104,042 1.386
PLLA/FeHA 10 wt %
0 98,633 55,206 1.787
16 94,867 53,228 1.782
20 92,094 53,123 1.734
25 52,704 32,946 1.600
PLLA/FeHA 30 wt %
0 66,625 47,961 1.389
5 55,750 30,984 1.799
16 49,382 20,093 2.458
20 89,927 45,269 1.986
25 49,972 36,484 1.370
(*) 10,668 9,873 1.081
PLLA/FeHA 70 wt %
0 81,855 44,573 1.836
15 98,065 45,623 2.149
25 86,760 53,289 1.628
(*) 10,982 10,511 1.045
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While the mass remained unchanged during degradation, the decrease in molecular weight
was clear (see Table 3). The decreases, however, were not very large due to the high crystallinity
of the scaffolds. This behavior can be explained by the aqueous solution penetrating the polymer
and initiating the process of hydrolytic degradation during the first stage of hydrolysis, mainly
in the amorphous regions. At this stage, a rapid decrease in molecular weight was observed, but
with no significant loss of mass, because the broken molecules were still not soluble in water and
remained inside the sample. In the second step, the mass loss increased, and the formation of a
lactic acid monomer was observed with a slight change in molecular weight. At this point, the long
polymer chains were converted into shorter water-soluble fragments that dissolved in the medium.
PLLA solubilizes in water at Mn ≤ 20,000 [27] during the 25th week of degradation. Looking carefully
at Table 3, one might think that the scaffolds are at the end of the first stage of the degradation process.
For compositions of PLLA/FeHA 30 wt % and 70 wt % after 25 weeks of degradation, a second peak
appeared in the GPC with a longer retention time, corresponding to smaller chains. At the end of the
degradation process, a decrease in the values of Mw and Mn of approximately 50% was observed for
the samples with the lowest percentage of nanoparticles.
In Figure 7, the change in size and morphology of the PLLA/FeHA 10 wt % sample can be
observed before and after the in vitro degradation process. Although mass remained invariable,
the same could not be said of molecular weight. The chains split to form smaller ones, because the
macromolecular chains could be trapped in the crystalline regions, due to the high crystallinity of
the polymer.
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IR spectra of the scaffolds were recorded with Fourier-transform infrared (FTIR) sp ctroscopy
and an attenu ted total reflectance (ATR) accessory, so as not to modify the sa ples. FeHA, PLLA,
and PLLA/FeHA 70 wt % absorption spectra can be observed in Figure 8. It shows how some bands
vary slightly in position, which may be indicative of interactions betwe n the calcium and iron cations
of the nanoparticles and the carbonile polymer groups. These bands are: stretchi g C=O displaced
from 1748 m−1 to 1760 1, stretching C–O displaced from 1180 c −1 to 1187 cm−1 and from
1080 cm−1 to 1088 cm−1.
t 1045 c − , r s t i t r l er, overlapped with the ν3PO43 l c t
et ee 1087–1032 cm−1 of the na ohydroxyapatite. It is worth mentioni g the appearance of inverted
bands in the PLLA/FeHA 70 wt % composite spectra. This anomalous f rm f IR band is due to the
“Christiansen effect” [34].
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Figure 8. Fourier-transform infrared spectroscopy (FTIR) spectra of FeHA, PLLA/FeHA 70 wt % and
pure PLLA.
In Figure 8, the vibration modes of the PO43− group in relation to the absorption of PLLA/FeHA
70 wt % were ν1, ν2 and ν4, whereas mode ν1 was present at 962 cm−1, mode ν3 appeared at 1087 and
1032 cm−1, and the band at 603 cm−1 was attributed to vibration mode ν4. A double peak was observed
at 1457 and 1420 cm−1, attributed to the ν3 CO32− vibration mode, which is a carbonate ion type B
deficient in Ca [35].
In Figure 9a,b, the spectra of the samples of PLLA/FeHA 30 wt % and 70 wt % during the
degradation process can be observed. There are no appreciable changes, as might be expected, in the
C=O band at 1760 cm−1, because of hydrolysis-induced splitting that caused bond breakage, due to
the saturation of the band. However, in their analysis of the hydrolytic degradation of aliphatic
polyesters by FTIR, Partini et al. focused their study on the band at 1570 cm−1, corresponding to the
carboxylic end groups. In this study, the 1570 cm−1 band was not appreciable for the polyester prior to
degradation, although it started to appear during degradation [35]. The appearance of the carbonyl
end band was not observed in any of the compositions, so there was no evidence of degradation in
this system during the 25 weeks of in vitro degradation.
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3.9. Cytotoxicity
The tissue engineering potential of the samples in biomedical applications was evaluated by
studying the cytotoxicity of the PLLA-based composites with different concentration of Fe3O4 and
FeHA. The effect of the polymer extract medium on the metabolic activity of the MC3T3-E1 cells was
performed using the MTT assay, and the results after 72 h are presented in Figure 10.
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Figure 10. Cell viability of MC3T3-E1 pre-osteoblast cells in contact with the as-prepared extraction
media exposed with the different samples up to 72 h.
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Neat PLLA has previously been reported as biocompatible and not cytotoxic [36]. According to
the ISO standard 10993-5, materials are considered cytotoxic when the cells suffer a viability
reduction larger than 30%, which occurred in the study’s PLLA samples with 20%, 50% and 70%
FeHA. The samples containing Fe3O4 were not cytotoxic, in agreement with the studies of other
researchers [37]. In relation to the samples with FeHA, and because both PLLA and hydroxyapatite [38]
are not cytotoxic, some of the synthesized products used for the preparation of the samples may have
remained encapsulated within the materials or in the interfacial regions, leading to cytotoxicity for
concentrations above 20% FeHA. Figure 11 shows the cell morphology of MC3T3-E1 pre-osteoblastos
seeded on PLLA after three days.
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4. Conclusions
In this study, novel PLLA magnetic nanohydroxyapatite scaffolds were prepared and fully
characterized. The ferromagnetic behavior of the scaffolds was confirmed by the rapid saturation and
appreciable coercivity of the magnetization curves of the magnetic particles, approximately 30 nm in
size, intermeshed in the scaffolds. The study of the scaffold morphologies identifies a liquid–liquid
separation system in the fabrication process with proportions of magnetic nanoparticles of over
20%. Although changes in molecular weight were observed during in vitro degradation, almost
no mass loss was observed, due to the entrapment of the macromolecular chains in the crystalline
regions and the high crystallinity of the polymer. The DSC results of percentage crystallinity, Xc%,
have presumably diminished MNP crystallinity, thereby reducing the mobility of the chains and
leaving some synthesized products encapsulated in the structure of the scaffolds.
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